Evidence map›Paper›PMID 42585024›Full record

ArticleCell reports2026

Humanizing acidic mammalian chitinase variants establish lung immune conditioning and control environmentally driven inflammation and fibrosis.

Yilin Wang, Haerin Jung, Do-Hyun Kim, Eilene Liu, Donovan Watza, Samuel I Risma, Kira L Florczak, Leah M Kim, Zeena Bou Reslan, Ananya Gupta and 6 more

Abstract read
In one paragraph

Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yilin WangDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Haerin JungDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Do-Hyun KimDepartment of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, Republic of Korea; Research Institute for Natural Sciences, Hanyang University, Seoul, Republic of Korea; Research Institute for Convergence of Basic Sciences, Hanyang University, Seoul 04763, Republic of Korea.
Eilene LiuDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Donovan WatzaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Samuel I RismaDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Kira L FlorczakDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Leah M KimDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Zeena Bou ReslanDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Ananya GuptaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Ruppal SoniDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Roberto Efraín DíazDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
Richard M LocksleyDepartment of Microbiology & Immunology, University of California, San Francisco, San Francisco, CA, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.
James S FraserDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
Janet S LeeDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Steven J Van DykenDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: svandyken@wustl.edu.

Funding

PRINCIPLES IN PULMONARY RESEARCHT32HL007317 · NHLBI · WASHINGTON UNIVERSITY · PI Steven Brody, Michael J Holtzman · 1985 to 2026
$16.1M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
CLINICAL/LABORATORY TRAINING ACADEMIC GASTROENTEROLOGYT32DK007130 · NIDDK · WASHINGTON UNIVERSITY · PI MATTHEW AARON CIORBA · 1986 to 2026
$8.3M
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Christine T. Pham · 2018 to 2026
$7.6M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
Defining the role of IL-18 in atopic dermatitisR01AI176660 · NIAID · WASHINGTON UNIVERSITY · PI Brian Kim, Steven Van Dyken · 2023 to 2026
$3.3M
Targeting chitin in fibrotic lung diseaseR01HL148033 · NHLBI · WASHINGTON UNIVERSITY · PI VAN DYKEN, STEVEN · 2020 to 2023
$1.7M
Spatiotemporal control of early matricellular events in the injured lungR01HL177904 · NHLBI · WASHINGTON UNIVERSITY · PI Jaehyung Cho, Janet Sojung Lee · 2025 to 2026
$1.5M
Chitin and chitinases in SARS-CoV-2 infectionR21AI163640 · NIAID · WASHINGTON UNIVERSITY · PI VAN DYKEN, STEVEN · 2023 to 2024
$428k
NHLBI NIH HHS 75N92020D00005NHLBI NIH HHS R01 HL148033NHLBI NIH HHS R01 HL177904NHLBI NIH HHS T32 HL007317NIAID NIH HHS 75N93022D00005NIAID NIH HHS R01 AI176660NIAID NIH HHS R21 AI163640NIAID NIH HHS T32 AI007163NIAMS NIH HHS P30 AR073752NIDA NIH HHS 75N95020D00005NIDDK NIH HHS T32 DK007130NIH HHS 75N93023D00005NIH HHS 75N99020D00005
6 · The paper itself

Abstract

Chitin, a widespread environmental particle constituent, triggers lung inflammation but is degraded by chitinases. In humans, single-nucleotide polymorphisms (SNPs) in CHIA (acidic mammalian chitinase; AMCase) are associated with lung disease, suggesting that chitinase variants influence responses to airborne particles. Here, we edit the mouse Chia1 locus to generate humanized (hChia) mice harboring common human SNPs. Compared with controls expressing disease-protective SNPs, hChia mice lack robust chitinase activity and fail to degrade natural chitin substrates. Lung-resident lymphocytes and macrophages are spontaneously primed and sensitive to inflammatory triggering by environmental chitin. Immune cell infiltration correlates with airway chitin following challenge, and hChia mice exhibit exacerbated inflammatory and fibrotic lung disease. In humans with acute respiratory failure, alveolar hemorrhage coincides with environmentally derived chitin particles that are susceptible to chitinase degradation, attenuating inflammatory cell responses. Thus, environmental chitin and chitinase activity are crucial determinants of lung immune conditioning with potential therapeutic applications.

Indexed as

alveolar macrophagesAMCaseCHIAchitinchitinaseCP: genomicsCP: immunologygene-environment interactionIL-1β signalingimmune conditioninglung inflammationpulmonary fibrosis

Identifiers

PMID42585024
PMCPMC13600261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.